<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100816004578N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-03-14</date_registration>
      <primary_sponsor>Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences</primary_sponsor>
      <public_title>Impact of two types of indwelling catheter in prevention catheter-associated urinary tract infectionson</public_title>
      <acronym>پیشگیری</acronym>
      <scientific_title>Comparison of two types of indwelling catheter in prevention catheter-associated urinary tract infections in ICU patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/37227</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: All patients with entry criteria will be identified. Then, the allocation of patients to the Foley catheter group or the LoPro urinary catheter will be randomized. The computer generated randomization list is first generated and the randomly assigned duplicate blocks (1: 1) are printed on paper and packed in envelopes. Each envelope will be opened after receiving written consent from the patient's ward, Blinding description: Since patients with a decreased level of consciousness, blind blindness is not conceptualized. The laboratory warden will not be aware of the groups being studied. Also, since the difference is only in the physical structure of the bladder end of the catheter and the visible parts in the two types of catheter are similar, therefore, nurses working in the ICU will not be aware of the type of catheter used for the patient.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Urinary tract infection.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group of a type of catheter with oval holes on both sides, the LoPro (Low Profile) catheter is a short and an end tip slightly higher than the balloon loop. Intervention 2: Control group:Use Foley Root Catheter in section.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the studied demographic and clinical characteristics will be issued.

When:
The study protocol will be issued in the article.

To whom:
After publishing the results, the data will be provided to the requesting users.

Conditions:
The data will be available for use in the systematic review and meta-analysis studies.

Where to obtain:
Dr. Mahnaz Kitaban and Mrs. Farahnaz Ramezani (Project executives)

How to obtain:
By sending an email request to the project executives.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farshid Rahimi Bashar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>General ICU, BESAT Hospital, Motahhari boulevard, Resalat Square, Hamedan</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6514845411</zip>
        <telephone>+98 81 3264 0025</telephone>
        <email>frahimi@umsha.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Farshid Rahimi Bashar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>General ICU, BESAT Hospital, Motahhari boulevard, Resalat Square</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>65148454411</zip>
        <telephone>+98 81 3264 0025</telephone>
        <email>f.rahimi@umsh.ac.ir</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Decreased consciousness (less than 9 in GCS)
Normal body temperature (as axillary 35.5-37%)
The doctor's order for urinary catheterization
Not having a urinary tract infection or bacteriuria prior to admission
Not having underlying diseases such as diabetes, CKD, nephrosclerosis, acute or chronic glomerulonephritis, and pyelonephritis
Not having immune deficiency disorders such as lupus erythematosus, rheumatoid arthritis, MS
Not having trauma and rupture of the urethra and bladder
Not getting aminoglycoside medications
Age over 18 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Exit the catheter for any reason (exits by patient or on doctor's instructions) before 3 days
Death or transmission of the patient before the completion of the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N30.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other chronic cystitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group of a type of catheter with oval holes on both sides, the LoPro (Low Profile) catheter is a short and an end tip slightly higher than the balloon loop</i_keyword>
      <i_keyword>Control group:Use Foley Root Catheter in section</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Number Bacteria. Timepoint: Before and After 1،2،3 days. Method of measurement: Urine Culture.</prim_outcome>
      <prim_outcome>Type of Bacteria. Timepoint: Before and After 1،2،3 days. Method of measurement: Urine Culture.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>ESR. Timepoint: Before and After 3 days. Method of measurement: Vstrgryn.</sec_outcome>
      <sec_outcome>Leukocytosis. Timepoint: Before and After 3 days. Method of measurement: Cell Blood Count.</sec_outcome>
      <sec_outcome>Nitrite. Timepoint: Before and After 1.2.3 days. Method of measurement: Urinalysis.</sec_outcome>
      <sec_outcome>Body temperature. Timepoint: Before and After 1.2.3 days. Method of measurement: Axillary with medical thermometer.</sec_outcome>
      <sec_outcome>PH of the urine. Timepoint: Before and After 1.2.3 days. Method of measurement: DIP STICK.</sec_outcome>
      <sec_outcome>The color of the urine. Timepoint: Before and After 1.2.3 days. Method of measurement: DIP STICK.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for Research and Technology of Hamadan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-01-28</approval_date>
        <contact_name>Ethics Committee of Hamedan University of Medical Sciences</contact_name>
        <contact_address>Hamadan University of Medical Science, Shahid Fahmide boulevard, Hamadan Hamedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
